Saturday, June 6, 2026
28.9
C
Bengaluru
Hot topics
Vivek V. Kamath Appointed CEO at PlasmaGen BioSciences
Picture: Deep Bhandari led session at ACG - MedicinMan...
Navigating India’s Diverging Health Landscape and Field Force Optimisation
India’s health map is splitting into two distinct opportunity...
Tariffs and Indian Generics: Is Trump Cutting His Nose to Spite His Face?
Trump’s Tariffs Threaten US Drug Affordability The Value of...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?
A quiet but revolutionary milestone may be unfolding in...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Hot topics
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality
Abstract
When Intas Pharmaceuticals launched Razumab in June 2015 as...
Cipla’s Leadership Transition from Umang Vohra to Achin Gupta: Succession Planning in Action
By Anup Soans | MedicinMan
Cipla Limited has announced a...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Newsletter
Get important news delivered directly to your inbox and stay connected!